Raymond Joseph Tesi
Net Worth

Last updated:

What is Raymond Joseph Tesi net worth?

The estimated net worth of Dr. Raymond Joseph Tesi is at least $2,460,226 as of 12 Sep 2024. He owns shares worth $37,066 as insider, has earned $623,160 from insider trading and has received compensation worth at least $1,800,000 in INmune Bio, Inc..

What is the salary of Raymond Joseph Tesi?

Dr. Raymond Joseph Tesi salary is $300,000 per year as Co-Founder, Pres, Chief Executive Officer, Chief Medical Officer & Chairman in INmune Bio, Inc..

How old is Raymond Joseph Tesi?

Dr. Raymond Joseph Tesi is 69 years old, born in 1956.

What stocks does Raymond Joseph Tesi currently own?

As insider, Dr. Raymond Joseph Tesi owns shares in one company:

Company Title Shares Price per share Total value
INmune Bio, Inc. (INMB) Co-Founder, Pres, Chief Executive Officer, Chief Medical Officer & Chairman 15,380 $2.41 $37,066

What does INmune Bio, Inc. do?

INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma and patients with high-risk myelodysplastic syndrome; INB03, an immunotherapy that treats patients with hematologic malignancies and solid tumors; and XPro1595 for the treatment of Alzheimer's disease. The company has license agreements with Xencor, Inc.; Immune Ventures, LLC; University of Pittsburg; and University College London. INmune Bio, Inc. was incorporated in 2015 and is headquartered in Boca Raton, Florida.

INMB logo
INMB
INmune Bio, Inc.
$2.41

Raymond Joseph Tesi insider trading

INmune Bio, Inc.

Dr. Raymond Joseph Tesi has made 5 insider trades between 2019-2024, according to the Form 4 filled with the SEC. Most recently he purchased 15,380 units of INMB stock worth $98,048 on 12 Sep 2024.

The largest trade he's ever made was exercising 30,000 units of INMB stock on 25 Aug 2021. As of 12 Sep 2024 he still owns at least 15,380 units of INMB stock.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 15,380 $6.38 $98,048
Purchase
Common Stock Warrants (right to buy) 15,380 $6.4 $98,432
Purchase
Common Stock 18,028 $8.32 $149,993
Purchase
Common Stock Warrants (right to buy) 18,028 $9.15 $164,992
Purchase
Common Stock 6,300 $6.41 $40,383
Sale
Common Stock 1,025 $20 $20,500
Sale
Common Stock 6,517 $20 $130,340
Sale
Common Stock 23,616 $20 $472,320
Option
Employee Stock Option (right to buy) 30,000 $3.91 $117,300
Option
Common Stock 30,000 $3.91 $117,300
Sale
Common Stock 24,351 N/A N/A
Sale
Common Stock 5,649 N/A N/A
Purchase
Common Stock 2,000 N/A N/A
Purchase
Common Stock 2,000 $5.93 $11,868
Purchase
Common Stock 2,000 $5.93 $11,868
Purchase
Common Stock 2,000 N/A N/A
Purchase
Common Stock 2,000 $7.08 $14,168
Purchase
Common Stock 2,000 $7.08 $14,168
Purchase
Common Stock 2,000 N/A N/A
Purchase
Common Stock 10,000 N/A N/A
Purchase
Common Stock 11,100 N/A N/A

INmune Bio key executives

INmune Bio, Inc. executives and other stock owners filed with the SEC:

  • Dr. Mark William Lowdell BSc, MSc, Ph.D., FRCPath, MICR (62) Chief Scientific Officer & Chief Manufacturing Officer
  • Dr. Raymond Joseph Tesi (69) Co-Founder, Pres, Chief Executive Officer, Chief Medical Officer & Chairman
  • Mr. David J. Moss M.B.A. (55) Chief Financial Officer, Treasurer & Sec.